Chronic Kidney Disease (CKD) Trials
Start Your CKD Study on the Right Track
Meeting the Challenges of CKD Trials Head On
Chronic Kidney Disease (CKD) and end-stage renal disease (ESRD) represent significant mortality rates across the globe. To improve treatment outcomes and quality of life for patients, and ensure that clinical trials are on track and on time for sponsors, Biorasi leverages our expertise in nephrology and project management to prevent potential obstacles and delays to CKD and rare nephrology disease trials including:
- Performance as a full-service CRO with expertise in CKD
- Identification and recruitment of patients with specific nephropathies
- Retention of enrolled patients and adherence to treatment
- Capture and analysis of data across multiple mediums to inform trial results
Biorasi Brings Challenging CKD Studies Under Control
Biorasi’s experience in recruitment for nephrology trials significantly impacts enrollment for clinical studies with robust patient engagement and access to global patient populations. Once patients have been screened and approved, we support our partners in trial participation solutions ranging from education and training to remote patient monitoring solutions.
Throughout the CKD study, Biorasi’s TALOS™ system is able optimize data intelligence – collecting key metrics through multiple physical and digital sources and standardizing the results for analysis. Our technology also allows for 24/7 real-time reporting, enabling data review at key milestones in the trial.